Publicaciones científicas

/cun/investigacion/publicaciones-cientificas/areaMain/02
  • Preclinical safety of topically administered nanostructure lipid carriers (NLC) for wound healing application: biodistribution and toxicity studies

    Vairo C (1), Collantes M (2), Quincoces G (2), Villullas S (3), Peñuelas I  (4), Pastor M (3), Gil AG (5), Gainza E (3), Hernandez RM (6), Igartua M (6), Gainza G (7).

    (1) BioKeralty Research Institute AIE, Albert Einstein, 25-E3, 01510 Miñano, Araba, Spain; NanoBioCel Group, Laboratory of Pharmaceutics, University of the Basque Country (UPV/EHU), School of Pharmacy, Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.
    (2) Nuclear Medicine Department, Clínica Universidad de Navarra, Pamplona, Spain.
    (3) BioKeralty Research Institute AIE, Albert Einstein, 25-E3, 01510 Miñano, Araba, Spain.
    (4) Nuclear Medicine Department, Clínica Universidad de Navarra, Pamplona, Spain; Small Animal Imaging Research Unit, Center for Applied Medical Research (CIMA) and Clínica Universidad de Navarra, Pamplona, Spain.
    (5) Department of Pharmacology and Toxicology, University of Navarra, 31008 Pamplona, Spain; Toxicology Unit, Drug Development Unit University of Navarra (DDUNAV), 31008 Pamplona, Spain.
    (6) NanoBioCel Group, Laboratory of Pharmaceutics, University of the Basque Country (UPV/EHU), School of Pharmacy, Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain.
    (7) BioKeralty Research Institute AIE, Albert Einstein, 25-E3, 01510 Miñano, Araba, Spain

    International Journal of Pharmaceutics 28 de JUNIO de 2019

  • Mannosylated nanoparticles for oral immunotherapy in a murine model of peanut allergy

    Brotons-Canto A (1), Gamazo C (1), Martín-Arbella N (1), Abdulkarim M (2), Gumbleton M (2), Quincoces G (3), Peñuelas I (3), Irache JM (4).

    (1) NANO-VAC Research Group, Instituto de Investigación Sanitaria de Navarra (IdiSNA), University of Navarra, 31008, Pamplona, Spain.
    (2) School of Pharmacy and Pharmaceutical Science, Cardiff University, Cardiff, UK.
    (3) Radiopharmacy Unit, Department of Nuclear Medicine, Clinica Universidad de Navarra, University of Navarra, Spain.
    (4) NANO-VAC Research Group, Instituto de Investigación Sanitaria de Navarra (IdiSNA), University of Navarra, 31008, Pamplona, Spain.

    Journal of Pharmaceutical Sciences 05 de MARZO de 2019

  • Modulation of the fate of zein nanoparticles by their coating with a Gantrez® AN-thiamine polymer conjugate

    Inchaurraga L (1), Martínez-López AL (1), Abdulkarim M (2), Gumbleton M (2), Quincoces G (3), Peñuelas I (3), Martin-Arbella N (1), Irache JM (1).

    (1) NANO-VAC Research Group, Department of Chemistry and Pharmaceutical Technology, University of Navarra, Spain.
    (2) School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK.
    (3) Radiopharmacy Unit, Department of Nuclear Medicine, Clinica Universidad de Navarra, University of Navarra, Spain.

    International Journal of Pharmaceutics: X 25 de ENERO de 2019

  • Increased Oral Bioavailability of Resveratrol by Its Encapsulation in Casein Nanoparticles

    Peñalva R (1), Morales J (2), González-Navarro CJ (3), Larrañeta E (4), Quincoces G (5), Peñuelas I (6), Irache JM (7).

    (1) NANO-VAC Research Group, Department of Pharmacy and Pharmaceutical Technology, University of Navarra, 31008 Pamplona, Spain.
    (2) NANO-VAC Research Group, Department of Pharmacy and Pharmaceutical Technology, University of Navarra, 31008 Pamplona, Spain. 
    (3) Centre for Nutrition Research, University of Navarra, 31080 Pamplona, Spain. 
    (4) NANO-VAC Research Group, Department of Pharmacy and Pharmaceutical Technology, University of Navarra, 31008 Pamplona, Spain.
    (5) Radiopharmacy Unit, Department of Nuclear Medicine, Clinica Universidad de Navarra, University of Navarra, 31008 Pamplona, Spain.
    (6) Radiopharmacy Unit, Department of Nuclear Medicine, Clinica Universidad de Navarra, University of Navarra, 31008 Pamplona, Spain. 
    (7) NANO-VAC Research Group, Department of Pharmacy and Pharmaceutical Technology, University of Navarra, 31008 Pamplona, Spain.

    International Journal of Molecular Sciences 18 de SEPTIEMBRE de 2018

  • Radiation dosimetry and biodistribution in non-human primates of the sodium/iodide PET ligand [18F]-tetrafluoroborate

    Marti-Climent JM (1,2), Collantes M (3,4,5), Jauregui-Osoro M (6), Quincoces G (7,8), Prieto E (9,10), Bilbao I (11,12), Ecay M (13), Richter JA (14,15), Peñuelas I (16,17,18).
    (1) Department of Nuclear Medicine, Clínica Universidad de Navarra, Avda. Pío XII, 36, 31008, Pamplona, Spain.
    (2) Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
    (3) Department of Nuclear Medicine, Clínica Universidad de Navarra, Avda. Pío XII, 36, 31008, Pamplona, Spain.
    (4) Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
    (5) Small Animal Imaging Research Unit, Center for Applied Medical Research (CIMA) - Clínica Universidad de Navarra, Pamplona, Spain.
    (6) Division of Imaging Sciences, King's College, London, UK. maite.jauregui-osoro@kcl.ac.uk.
    (7) Department of Nuclear Medicine, Clínica Universidad de Navarra, Avda. Pío XII, 36, 31008, Pamplona, Spain.
    (8) Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
    (9) Department of Nuclear Medicine, Clínica Universidad de Navarra, Avda. Pío XII, 36, 31008, Pamplona, Spain.
    (10) Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
    (11) Small Animal Imaging Research Unit, Center for Applied Medical Research (CIMA) - Clínica Universidad de Navarra, Pamplona, Spain.
    (12) Fundación Centro Nacional de Investigaciones Cardiovasculares (CNIC) - CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
    (13) Small Animal Imaging Research Unit, Center for Applied Medical Research (CIMA) - Clínica Universidad de Navarra, Pamplona, Spain. 
    (14) Department of Nuclear Medicine, Clínica Universidad de Navarra, Avda. Pío XII, 36, 31008, Pamplona, Spain.
    (15) Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
    (16) Department of Nuclear Medicine, Clínica Universidad de Navarra, Avda. Pío XII, 36, 31008, Pamplona, Spain.
    (17) Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
    (18) Small Animal Imaging Research Unit, Center for Applied Medical Research (CIMA) - Clínica Universidad de Navarra, Pamplona, Spain.

    EJNMMI Research 05 de DICIEMBRE de 2015

tal vezLE INTERESE

¿QUÉ TECNOLOGÍA UTILIZAMOS?

La Clínica es el hospital privado con mayor dotación tecnológica de España, todo en un único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

NUESTROS
PROFESIONALES

Los profesionales de la Clínica realizan una labor continuada de investigación y formación, siempre en beneficio del paciente.

Imagen profesionales de la Clínica Universidad de Navarra

POR QUÉ VENIR
A LA CLÍNICA

Conozca por qué somos diferentes a otros centros sanitarios. Calidad, rapidez, comodidad y resultados.

Imagen del edificio de la Clínica Universidad de Navarra